BREAKING: RDIF and Panacea Biotec launch the production of Sputnik V in India. #India's Panacea Biotec now to produce 100 million doses of #SputnikV per year 👇 https://sputnikvaccine.com/newsroom/pressreleases/rdif-and-panacea-biotec-launch-the-production-of-sputnik-v-in-india/ | Sputnik V
0:24
BREAKING: RDIF and Panacea Biotec launch the production of S…
13.2K viewsMay 24, 2021
FacebookSputnik V
Panacea Biotec on Tie Up With Apotex
15:08
Panacea Biotec on Tie Up With Apotex
Dec 18, 2014
NDTVHeena Gambhir,Anisha Nayar Dhawan
Indian firm Panacea Biotec begins production of Sputnik V vaccines. It will annually manufacture 100 million doses of Sputnik V. Video source: Russian Direct Investment Fund (RDIF) | Jammu Links News
0:21
Indian firm Panacea Biotec begins production of Sputnik V vaccines…
11K viewsMay 24, 2021
FacebookJammu Links News
Sputnik V production begins; RDIF, Panacea Biotec to make 10 crore doses per year
Sputnik V production begins; RDIF, Panacea Biotec to make 10 crore …
May 24, 2021
INDIA TV
RDIF, Panacea Biotec start Sputnik V Covid vaccine production in India
RDIF, Panacea Biotec start Sputnik V Covid vaccine production in India
May 24, 2021
India TodaySneha Mordani
COVID-19: Panacea Biotech to produce 100 million Sputnik V doses per year Watch more on Republic World ► http://bit.ly/2QoRSt0 | Republic
4:06
COVID-19: Panacea Biotech to produce 100 million Sputnik V dos…
52.5K viewsMay 24, 2021
FacebookRepublic
Panacea Biotec collaborates with Serum Institute for new hexavalent vaccine for infants
Panacea Biotec collaborates with Serum Institute for new hexavalen…
Jan 22, 2018
Moneycontrol
ICMR and Panacea Biotec announces initiation of Phase 3 clinical trial for a dengue vaccine in India - Public TV English
ICMR and Panacea Biotec announces initiation of Phase 3 cl…
Aug 14, 2024
publictv.in
India Moves Closer To Dengue Vaccine As Final Trials Underway Panacea Biotec has begun final Phase III trials of its vaccine, DengiAll, in a research effort the company has pursued for nearly 15 years. #denguevaccine #DengiAll #madeinindia #PanaceaBiotec #MedicalBreakthrough #PublicHealth #phase3trial #DenguePrevention #AtmanirbharBharat #healthnewsindia | ETV Bharat
5:14
India Moves Closer To Dengue Vaccine As Final Trials Underway …
67 views3 weeks ago
FacebookETV Bharat
इस कंपनी ने दी एक जानकारी, फिर उमड़ पड़े निवेशक, शेयर में 20% की तूफानी तेजी
इस कंपनी ने दी एक जानकारी, फिर उमड़ पड़े निवेशक, शेय…
Oct 11, 2022
aajtak.in
Panacea Bio receives license from DCGI to produce Sputnik V vaccine
Panacea Bio receives license from DCGI to produce Sputnik V vaccine
Jul 5, 2021
india.com
RDIF and Panacea Biotec to manufacture Sputnik V vaccine in India
1:32
RDIF and Panacea Biotec to manufacture Sputnik V vaccine in …
May 24, 2021
India TodayIndia Today Television
Corona के हर वैरिएंट पर काम करने वाली वैक्सीन बनाएगी Panacea Biotec, केंद्र के साथ हुआ समझौता | Zee Business
Corona के हर वैरिएंट पर काम करने वाली वैक्सीन बनाएग…
Feb 21, 2022
zeebiz.com
Panacea Biotec shares shoot up 13% on US FDA approval for migraine drug
Panacea Biotec shares shoot up 13% on US FDA approval for migr…
Jan 17, 2017
financialexpress.com
Panacea Biotec Launches EasyFourPol® in India and Receives Registration of Valganciclovir Powder for Oral Solution in Germany
Panacea Biotec Launches EasyFourPol® in India and Receiv…
Dec 14, 2023
marketscreener.com
Panacea Biotec says NCPHP issues statement of non-compliance with GMP
Panacea Biotec says NCPHP issues statement of non-compliance wit…
1 month ago
marketscreener.com
Panacea Biotec décroche un contrat de fourniture de vaccins d'environ 5 millions de dollars auprès de l'OPS
Panacea Biotec décroche un contrat de fourniture de vaccins d'enviro…
4 months ago
zonebourse.com
Order boost for Panacea Biotec: Rajesh Jain
5:40
Order boost for Panacea Biotec: Rajesh Jain
Dec 17, 2012
NDTVAshutosh Sharma
BIOPHARMACEUTICAL PROCESS DEVELOPMENT – TRENDS/ CHALLENGES/OPPORTUNITIES
1:03:11
BIOPHARMACEUTICAL PROCESS DEVELOPMENT – TRENDS/ CHAL…
1.3K viewsAug 19, 2022
YouTubeBiopharma Webinar Series
Serum Institute of India sells 0.65% stake in Panacea Biotec, details here - CNBC TV18
Serum Institute of India sells 0.65% stake in Panacea Biotec, details h…
Sep 18, 2023
cnbctv18.com
Panacea Biotec share rises 5% on Sputnik V vaccine production in India - BusinessToday
Panacea Biotec share rises 5% on Sputnik V vaccine production in I…
Jun 29, 2021
businesstoday.in
Panacea Biotec Technical Analysis
3:21
Panacea Biotec Technical Analysis
200 viewsAug 3, 2021
YouTubeCA Prashant Shah
Sputnik V to be made in India by Panacea Biotec, RDIF; Now, shortage of anti-fungal drug in Delhi, Maharashtra; more
44:15
Sputnik V to be made in India by Panacea Biotec, RDIF; Now, short…
May 24, 2021
India TodayIndia Today Television
Adar Poonawalla exits Panacea Biotec, sells entire stake for Rs 118 crore
Adar Poonawalla exits Panacea Biotec, sells entire stake for Rs 11…
May 18, 2021
india.com
UGRO Capital up by 11% this month; Panacea Biotec Pharma default on payment | Stocks to Watch
3:26
UGRO Capital up by 11% this month; Panacea Biotec Pharma d…
Nov 17, 2021
timesnownews.comVinnii Motiwala
Panacea Biotec | LinkedIn
Panacea Biotec | LinkedIn
Dec 17, 2022
linkedin.com
Inside the making of India's first dengue vaccine— DengiAll
8:23
Inside the making of India's first dengue vaccine— DengiAll
4.3K views2 months ago
YouTubeThePrint
Devender Gupta démissionne de son poste de directeur financier chez Panacea Biotec
Devender Gupta démissionne de son poste de directeur financier c…
3 months ago
zonebourse.com
India’s First Indigenous Dengue Vaccine? Panacea Biotec Hits Key Milestone | N18S
2:29
India’s First Indigenous Dengue Vaccine? Panacea Biotec Hits Ke…
8.4K views2 months ago
YouTubeCNBC-TV18
Panacea Biotec Completes Enrolment Of Study Participants In Its Dengue Vaccine Phase III Trial
2:16
Panacea Biotec Completes Enrolment Of Study Participants I…
133 views2 months ago
YouTubeCNBC-TV18
See more